Achieve Life Sciences (ACHV) EPS (Basic) (2010 - 2018)
Achieve Life Sciences' (ACHV) quarterly EPS (Basic) came in at -$20.72 in Q4 2018, up 86.72% YoY from -$11.1 in Q4 2017, and down 44.99% on a QoQ basis from -$14.29 in Q3 2018.
Achieve Life Sciences (ACHV) EPS (Basic) (2010 - 2018) Analysis & Trends
Achieve Life Sciences (ACHV) has 7 years of EPS (Basic) data on file, last reported at -$20.72 in Q4 2018.
- Quarterly EPS (Basic) rose 86.72% year-over-year to -$20.72 in Q4 2018, while the trailing twelve-month figure through Sep 2019 was -$8.98 (up 84.08% YoY) and the FY2019 annual result came in at -$39.76, up 44.99% from the prior year.
- EPS (Basic) eased to -$20.72 in Q4 2018, from -$14.29 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$12.16 in Q2 2017 to a low of -$260.18 in Q3 2017.
- A 4-year average of -$68.29 and a median of -$36.46 in 2018 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2017 — EPS (Basic) tumbled 776.45% — and 2018, when it soared 94.51%.
- Tracing ACHV's EPS (Basic) over 4 years: stood at -$103.91 in 2015, then jumped by 56.67% to -$45.03 in 2016, then sank by 246.49% to -$156.02 in 2017, then soared by 86.72% to -$20.72 in 2018.
- The last three EPS (Basic) figures came in at -$20.72 (Q4 2018), -$14.29 (Q3 2018), and -$36.46 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -20.72 |
| Sep 30, 2018 | -14.29 |
| Jun 30, 2018 | -36.46 |
| Mar 31, 2018 | -48.62 |
| Dec 31, 2017 | -156.02 |
| Sep 30, 2017 | -260.18 |
| Jun 30, 2017 | -12.16 |
| Mar 31, 2017 | -24.07 |
| Dec 31, 2016 | -45.03 |
| Sep 30, 2016 | -29.69 |
| Dec 31, 2015 | -103.91 |
| Dec 31, 2012 | -6,197.01 |
| Sep 30, 2012 | 890.90 |
| Jun 30, 2012 | 637.09 |
| Mar 31, 2012 | -1,474.63 |
| Dec 31, 2011 | -4,472.41 |
| Sep 30, 2011 | -1,009.94 |
| Jun 30, 2011 | 1,478.38 |
| Mar 31, 2011 | -689.69 |
| Dec 31, 2010 | -876.10 |